Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy

References

• Ashurst, I., et al., 2000. Latest advances in the development of dry powder inhalers. Pharmaceutical science and technology today, 3 (7), 246–256.
   PubMedGoogle Scholar
• Bendas, E.R. and Tadros, M.I., 2007. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS PharmSciTech, 8 (4), E07.
   PubMed Web of Science ®Google Scholar
• Bosquillon, C., et al., 2004. Aerosolization properties, surface composition and physical state of spray-dried protein powders. Journal of controlled release, 99 (3), 357–367.
   PubMed Web of Science ®Google Scholar
• Cai, X., et al., 2016. Preparation, characterization and pulmonary pharmacokinetics of a new inhalable zanamivir dry powder. Drug delivery, 23 (6), 1962–1971.
   PubMed Web of Science ®Google Scholar
• Carr, R.L., 1965. Evaluating flow properties of solids. Chemical engineering, 72, 163–168.
   Google Scholar
• Chen, X., et al., 2012. Liposomes prolongs the therapeutic effect of anti-asthmatic medication via pulmonary delivery. International journal of nanomedicine, 7, 1139–1148.
   PubMed Web of Science ®Google Scholar
• Chew, N.Y., et al., 2005. How much particle surface corrugation is sufficient to improve aerosol performance of powders? Pharmaceutical research, 22 (1), 148–152.
   PubMed Web of Science ®Google Scholar
• do Nascimento, E.G., et al., 2017. Tailoring drug release properties by gradual changes in the particle engineering of polysaccharide chitosan based powders. Polymers, 9 (12), 253.
   Google Scholar
• Edwards, D.A., et al., 1997. Large porous particles for pulmonary drug delivery. Science, 276 (5320), 1868–1871.
   PubMed Web of Science ®Google Scholar
• Ekambaram, P. and Sathali, A.A., 2011. Formulation and evaluation of solid lipid nanoparticles of ramipril. Journal of young pharmacists, 3 (3), 216–220.
   PubMedGoogle Scholar
• Elhissi, A.A., et al., 2006. Formulation generated from ethanol-based proliposomes for delivery via medical nebulizer. Journal of pharmacy and pharmacology, 58 (7), 887–894.
   PubMed Web of Science ®Google Scholar
• Elversson, J., et al., 2003. Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying. Journal of pharmaceutical sciences, 92 (4), 900–910.
   PubMed Web of Science ®Google Scholar
• Fry, D.W., White, C., and Goldman, D.J., 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. Analytical biochemistry, 90 (2), 809–815.
   PubMed Web of Science ®Google Scholar
• Goodman, L.S. and Gilman, A., 2006. Goodman and Gilman’s, the pharmacological basis of therapeutics. 11th ed. USA: McGraw Hill Publishers.
   Google Scholar
• Goula, A.M. and Adamopoulos, K.G., 2008. Effect of maltodextrin addition during spray drying of tomato pulp in dehumidified air: II. Powder properties. Drying technology, 26 (6), 726–737.
   Web of Science ®Google Scholar
• Honmane, S.M., et al., 2014. Comparative efficiency of formulation techniques for development of salbutamol sulphate loaded liposomes. International research journal of pharmacy, 5 (2), 70–74.
   Google Scholar
• Huang, Y.Y. and Wang, C.H., 2006. Pulmonary delivery of insulin by liposomal carriers. Journal of controlled release: official journal of the controlled release society, 113 (1), 9–14.
   PubMed Web of Science ®Google Scholar
• ICH harmonized tripartite guideline, 2003. Stability testing of new drug substances and products Q1A (R2). Version 4, 1–18. Available from: (https://www.ich.org/products/guidelines/quality/article/quality-guidelines.html [Accessed 18 September 2018]
   Google Scholar
• Johnston, M.J., et al., 2008. Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations. Journal of liposome research, 18 (2), 145–157.
   PubMed Web of Science ®Google Scholar
• Joshi, M. and Misra, A., 2001. Liposomal budesonide for dry powder inhaler: preparation and stabilization. AAPS PharmSciTech, 2 (4), 1–10.
   Google Scholar
• Lacerda, E.C., et al., 2016. Starch, inulin and maltodextrin as encapsulating agents affect the quality and stability of jussara pulp microparticles. Carbohydrate polymers, 151, 500–510.
   PubMed Web of Science ®Google Scholar
• Larhrib, H., et al., 2003. The influence of carrier and drug morphology on drug delivery from dry powder formulations. International journal of pharmaceutics, 257 (1–2), 283–296.
   PubMed Web of Science ®Google Scholar
• Lefort, R., et al., 2006. Mutarotational kinetics and glass transition of lactose. Solid state communications, 140 (7–8), 329–334.
   Web of Science ®Google Scholar
• Letsou, G.V., et al., 1999. Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression. The annals of thoracic surgery, 68 (6), 2044–2048.
   PubMed Web of Science ®Google Scholar
• Li, Q., et al., 2017. A review of the structure, preparation, and application of NLCs, PNPs, and PLNs. Nanomaterials, 7 (6), 122.
   Web of Science ®Google Scholar
• Liisa, M.L., Kirsi, P., and Kaarina, K., 1995. Decomposition of Salbutamol in aqueous solutions II. The effect of buffer species, pH, buffer concentration and antioxidants. International journal of pharmacy, 117 (2), 189–195.
   Web of Science ®Google Scholar
• Liu, F.Y., et al., 1993. Pulmonary delivery of free and liposomal insulin. Pharmaceutical research, 10 (2), 228–232.
   PubMed Web of Science ®Google Scholar
• Mojaverian, P., et al., 1997. In-vivo/in-vitro correlation of four extended release formulations of pseudoephedrine sulfate. Journal of pharmaceutical and biomedical analysis, 15 (4), 439–445.
   PubMed Web of Science ®Google Scholar
• Nizet, T.A., Broeders, M.E., and Folgering, H.T., 2004. Tremor side effects of salbutamol, quantified by a laser pointer technique. Respiratory medicine, 98 (9), 844–850.
   PubMed Web of Science ®Google Scholar
• Osmani, R.A., et al., 2017. Nanosponge carriers- an archetype swing in cancer therapy: a comprehensive review. Current drug targets, 18 (1), 108–118.
   PubMed Web of Science ®Google Scholar
• Osmani, R.A.M., et al., 2015. Microsponges based novel drug delivery system for augmented arthritis therapy. Saudi pharmaceutical journal, 23 (5), 562–572.
   PubMed Web of Science ®Google Scholar
• Palacio, M.A., et al., 2007. Solid- state characterization of two polymorphic form of R- albuterol sulphate. Journal of pharmaceutical and biomedical analysis, 43 (4), 1531–1534.
   PubMed Web of Science ®Google Scholar
• Ramana, M.V., et al., 2007. An approach to minimize Pseudomembranous colitis caused by clindamycin through liposomal formulation. Indian journal of pharmaceutical sciences, 69 (3), 390–393.
   Google Scholar
• Saari, M., et al., 1999. Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. International journal of pharmaceutics, 181 (1), 1–9.
   PubMed Web of Science ®Google Scholar
• Salunkhe, S.S., et al., 2014. Formulation, development and evaluation of ibuprofen loaded nanoemulsion prepared by nanoprecipitation technique: use of factorial design approach as a tool of optimization methodology. Journal of pharmaceutical investigation, 44 (4), 273–290.
   Google Scholar
• Staniforth, J.N., 1996. Improvement in dry powder inhaler performance: surface passivation effects. Drug delivery to the lungs, VII, 206–209.
   Google Scholar
• Sweetman, S. C., 2005. Martindale: the complete drug reference. London, UK: Pharmaceutical Press.
   Google Scholar
• Ten, R.M., et al., 2002. Interleukin-2 liposomes for primary immune deficiency using the aerosol route. International immunopharmacology, 2 (2–3), 333–344.
   PubMed Web of Science ®Google Scholar
• United State Pharmacopoeia (USP). 2004. The national formulary. 19th ed. 25th Review. Rockville, MD: US Pharmacopoeia convention.
   Google Scholar
• Vanbever, R., et al., 1999. Formulation and physical characterization of large porous particles for inhalation. Pharmaceutical research, 16 (11), 1735–1742.
   PubMed Web of Science ®Google Scholar
• Wu, L., et al., 2014. Studies on the spray dried lactose as carrier for dry powder inhalation. Asian journal of pharmaceutical sciences, 9 (6), 336–341.
   Google Scholar
• Zeng, X.M., et al., 2000. The influence of carrier morphology on drug delivery by dry powder inhalers. International journal of pharmaceutics, 200 (1), 93–106.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2018. Maltodextrin: a consummate carrier for spray-drying of xylooligosaccharides. Food research international (Ottawa, Ont.), 106, 383–393.
   PubMed Web of Science ®Google Scholar